Kegg medicus dgroup en
| DG01636 | |
| DG number | DG01636 |
| Classification | DGroup |
| Name | Insulin preparation TYPE Class |
| Stem | - |
| Structural formula |  |
| Member | DG01802 Human insulin D03230 Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN) D04541 Insulin human, isophane (USP) D04542 Insulin human zinc (USP) D04543 Insulin human zinc, extended (USP) D04547 Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN) D04550 Insulin zinc, prompt (USP) D04551 Insulin zinc (USP) D05622 Proinsulin human (USAN) D08080 Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18) DG01796 Insulin analog, fast-acting D04477 Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN) D04475 Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN) D04540 Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN) DG01797 Insulin analog, long-acting D03250 Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN) D04539 Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN) D09727 Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN) D10473 Insulin peglispro (USAN/INN) D12358 Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN) D00085 Insulin (JAN/USP) D10570 Insulin degludec (genetical recombination) and insulin aspart (genetical recombination) DG03229 Combination of insulin analog and GLP-1 receptor agonist D11034 Insulin glargine and lixisenatide D11567 Insulin degludec and liraglutide |
| Upper group | Antidiabetic agent |
| Remark | - |
| Comment | - |